AIT Therapeutics, Inc. (AITB) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 12 transactions totaling $236.8K, demonstrating a bearish sentiment with -$236.8K in net insider flow. The most recent transaction on Jan 1, 2019 involved a transaction of 12,000 shares valued at $0.
No significant insider buying has been recorded for AITB in the recent period.
No significant insider selling has been recorded for AITB in the recent period.
Based on recent SEC filings, insider sentiment for AITB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$236.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AIT Therapeutics, Inc. (AITB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading AITB stock, having executed 12 transactions in the past 90 days. The most active insider is Steven A. Lisi (Executive), who has made 3 transactions totaling $497.7K.
Get notified when executives and directors at AITB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2019 | A. Lisi Steven | Executive | Award | 12,000 | $N/A | $0 | |
| Jan 1, 2019 | Avniel Amir | Executive | Award | 12,000 | $N/A | $0 | |
| Dec 31, 2018 | A. Lisi Steven | Executive | Award | 88,000 | $N/A | $0 | |
| Dec 31, 2018 | Avniel Amir | Executive | Award | 45,000 | $N/A | $0 | |
| Jun 22, 2018 | Raved Ari | Executive | Sale | 74,000 | $3.20 | $236.8K | |
| Feb 16, 2018 | A. Lisi Steven | Executive | Option Exercise | 117,112 | $4.25 | $497.7K | |
| Feb 16, 2018 | Lucera Erick | Executive | Option Exercise | 1,171 | $4.25 | $5.0K | |
| Feb 16, 2018 | Grossman David | Executive | Option Exercise | 2,342 | $4.25 | $10.0K | |
| Feb 16, 2018 | Raved Ari | Executive | Option Exercise | 11,709 | $4.25 | $49.8K | |
| Feb 16, 2018 | Lee Yoori | Executive | Option Exercise | 2,342 | $4.25 | $10.0K | |
| Feb 16, 2018 | Avniel Amir | Executive | Option Exercise | 2,342 | $4.25 | $10.0K | |
| Feb 16, 2018 | Bentsur Ron | Executive | Option Exercise | 23,419 | $4.25 | $99.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 7 | $681.9K | 74.2% |
Sale(S) | 1 | $236.8K | 25.8% |
Award(A) | 4 | $0 | 0.0% |
Insider selling pressure at AIT Therapeutics, Inc. has increased, with 7 insiders executing 12 transactions across all time. Total sales of $236.8K significantly outpace purchases of $0, resulting in a net outflow of $236.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.